Marché mondial de la réaction en chaîne par polymérase (PCR) en temps réel – Tendances et prévisions du secteur jusqu’en 2030

 Analyse du marché et de la taille de la réaction en chaîne par polymérase (PCR) en temps réel

Les systèmes PCR en temps réel sont des instruments de laboratoire utilisés pour augmenter le nombre de copies de segments d'ADN spécifiques. La prévalence croissante des maladies chroniques et infectieuses stimule la croissance du marché de la réaction en chaîne par polymérase (PCR) en temps réel. En outre, les avancées de la recherche en criminalistique, en diagnostic et en protéomique créent des opportunités de croissance potentielles pour le marché de la réaction en chaîne par polymérase (PCR) en temps réel.

Français Data Bridge Market Research analyse que le marché de la réaction en chaîne par polymérase (PCR) en temps réel, qui était de 35 milliards USD en 2022, devrait atteindre 67,22 milliards USD d’ici 2030 et devrait connaître un TCAC de 8,50 % au cours de la période de prévision 2023 à 2030. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l’épidémiologie des patients, l’analyse du pipeline, l’analyse des prix et le cadre réglementaire.

Portée et segmentation du marché de la réaction en chaîne par polymérase (PCR) en temps réel  

Market Definition

The method that creates multiple copies of a particular DNA region in vitro uses the polymerase chain reaction. The technique relies on a DNA polymerase known as TAQ polymerase, which is thermostable. Thermus aquaticus is used to produce this polymerase. They occupy hot springs and hydrothermal vents. The target region to be reproduced is produced in large numbers by the PCR reaction, which involves repeat cycles at a range of temperatures.

Global Real-Time Polymerase Chain Reaction (PCR) Market Dynamics

Drivers

• Rising frequency of infectious diseases

The polymerase chain reaction (PCR) has been used and shown to be effective in detecting minute amounts of a wide range of infectious diseases. The best conditions for amplification vary depending on the organisms of interest. PCR was used as a rapid and sensitive method for detecting infectious agents, and three assay systems were developed, one for the amplification of human T cell leukaemia virus type I, one for Mycobacterium tuberculosis, and one for Mycoplasma pneumoniae. These all factors will propel the market.

Furthermore, the ageing population and the rising frequency of infectious diseases significantly impact the growth of the real time polymerase chain reaction (PCR) market.

• Rising research and development activities

The increased use of the polymerase chain reaction for cancer diagnosis is expected to drive market growth in the coming years. All of these factors are responsible for creating a greater demand for this technique in the coming years, research and development activities for providing innovative molecular biology and forensic science as there has been a great demand for genetic engineering as well as personalized medicines the market is expected to grow well during the forecast period.

Opportunities

• Rising demand for polymerase chain reaction

The majority of the market opportunities are due to increasing demand for personalized medicines. Technology gathering information at the molecular level to detect disease will be extremely useful. Polymerized chain reaction techniques are widely used in all screening methods. The introduction of the polymerase chain reaction boosted the biotechnology industry. Polymerase chain reaction is a vital component of both the life sciences and the pharmaceutical industry. As the devices are used on a large scale for drug discovery, the demand for polymerase chain reaction technology is expected to increase significantly in the coming years.

Restraints/Challenges

• High cost of technology

The technical limitations and high cost of technology will obstruct the market's growth rate.

Short detection window

The Real Time RT-PCR technique will only detect the presence of viral material during infection and will not reveal whether a person was infected, developed immunity, or recovered.

Negative results do not rule out COVID-19 infection and should not be used to guide patient management decisions.

This real-time polymerase chain reaction (PCR) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the real-time polymerase chain reaction (PCR) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Real-Time Polymerase Chain Reaction (PCR)

COVID-19 had a positive impact on the market. The need for accurate illness diagnosis increased during the COVID-19 pandemic outbreak. The polymerase chain reactions were in high demand from many nations throughout the world. Since the polymerase chain reaction was thought to be one of the most trustworthy methods, it was used for the majority of diagnoses. During the pandemic, there was a huge demand from both developing and developed countries for tests, reagents, and various items. The majority of industry participants, including Thermo Fisher Scientific, saw a rise in sales during the pandemic. The revenue earned by Thermo Fisher Scientific's bio sciences division was up by 77.5% from the prior years. The real-time polymerase chain reaction market grew during those years and is anticipated to continue growing well in the years to come as the COVID-19 pandemic epidemic expected for a longer period.

Global Real-Time Polymerase Chain Reaction (PCR) Market Scope

The real-time polymerase chain reaction (PCR) market is segmented on the basis of offering, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Offering

• Instruments
• Reagents
• Assay
• Panels and Consumables
• Software and Accessories

 Application

• Fish Species Detection
• microRNA Analysis
• Microplasma Species Detection
• Virus and Bacterial Analysis

End User

• Healthcare
• Pharmaceuticals
• Agriculture
• Others

Real-Time Polymerase Chain Reaction (PCR) Market Regional Analysis/Insights

The real-time polymerase chain reaction (PCR) market is analyzed and market size insights and trends are provided by country, offering, application and end user as referenced above.

The countries covered in the real-time polymerase chain reaction (PCR) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the real-time polymerase chain reaction (PCR) market owing to the rising occurrences of hepatitis, HIV, viral infections and other diseases.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the adoption of advanced technologies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The real-time polymerase chain reaction (PCR) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for real-time polymerase chain reaction (PCR) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the real-time polymerase chain reaction (PCR) market. The data is available for historic period 2011-2021.

Competitive Landscape and Real-Time Polymerase Chain Reaction (PCR) Market Share Analysis

The real-time polymerase chain reaction (PCR) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to real-time polymerase chain reaction (PCR) market.

Some of the major players operating in the real-time polymerase chain reaction (PCR) market are:

• Thermo Fisher Scientific Inc. (U.S.)
• Bio-Rad Laboratories Inc. (U.S.)
• Agilent Technologies, Inc. (États-Unis)
• bioMérieux (France)
• Merck KGaA (Allemagne)
• BioTools standard (États-Unis)
• Takara Bio Inc. (Japon)
• Beckman Coulter, Inc. (États-Unis)
• BD (États-Unis)
• Céphéide. (États-Unis)
• Eppendorf SE (Allemagne)
• General Electric (États-Unis)
• Séquençage Roche (États-Unis)
• PerkinElmer Inc. (États-Unis)
• Promega Corporation (États-Unis)
• Siemens (Allemagne) 

SKU-56784